Foundation Medicine-B (02616) received an increase of 2,420,500 shares from executive director Yang Jianxin and senior management.

Zhicheng Financial News APP announced that Cornerstone Pharmaceuticals-B (02616) has issued a notice. The company's CEO, Chief of Research and Development, and Executive Director Dr. Yang Jianxin (Dr. Yang), along with other directors and senior management, have informed that they collectively purchased a total of 2.4205 million shares in the open market in June 2026 (shareholding increase), with Dr. Yang purchasing 1.2375 million shares.